[68Ga]Ga-FAPI-46 PET in a Borderline Ovarian Tumor

[⁶⁸Ga]Ga-FAPI-46 PET in a Borderline Ovarian Tumor

J Nucl Med. 2024 Jan 11:jnumed.123.266732. doi: 10.2967/jnumed.123.266732. Online ahead of print.

Lena M Unterrainer^{1

2}, Sanaz Memarzadeh^{3

4

5

6

7}, Neda A Moatamed⁸, Matthias R Benz^{9

10}, Johannes Czernin⁹, Jeremie Calais⁹

¹ Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, UCLA, Los Angeles, California; lunterrainer@mednet.ucla.edu.
² Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany.
³ Jonsson Comprehensive Cancer Center, School of Dentistry and Medicine, UCLA, Los Angeles, California.
⁴ Department of Obstetrics and Gynecology, David Geffen School of Medicine, UCLA, Los Angeles, California.
⁵ Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research, UCLA, Los Angeles, California.
⁶ Molecular Biology Institute, UCLA, Los Angeles, California.
⁷ VA Greater Los Angeles Healthcare System, Los Angeles, California.
⁸ Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, UCLA, Los Angeles, California; and.
⁹ Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, UCLA, Los Angeles, California.
¹⁰ Department of Radiological Sciences, UCLA, Los Angeles, California.

No abstract available